Second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) who progressed to a first-line treatment containing BV: Updated results of the phase III 'BEBYP'trial by the Gruppo Oncologico Nord Ovest (GONO)

Authors :: GIANLUCA MASI
Loupakis, F.
Salvatore, L.
CHIARA CREMOLINI
Fornaro, L.
Schirripa, M.
Granetto, C.
Miraglio, E.
Di Costanzo, F.
Antonuzzo, L.
Marcucci, L.
Barbara, C.
Boni, C.
Banzi, M.
Chiara, S.
Garbarino, D.
Valsuani, C.
Bonetti, A.
Boni, L.
Alfredo Falcone
Source :: Università di Pisa-IRIS
Publication Year :: 2013
Publisher :: American Society of Clinical Oncology, 2013.

Tools